NextCure Inc (NXTC) Live Share Price, Invest From India

NextCure Inc Stock Performance

as on April 18, 2026 at 6:59 am IST

Day's Low
Day's High
$10.13
Day's Price Range
$11.05
$10.20
0.69%
Downside
8.33%
Upside
52 Week's Low
52 Week's High
$3.85
52-Week Price Range
$15.74
$10.20
62.24%
Downside
54.31%
Upside

NextCure Inc share price movements today

Previous Close: $11.00
Open: $11.00
Volume: 318.8K
Day's Low - High: $10.13 - $11.05
52 Week Low - High: $3.85 - $15.74

NextCure Inc Historical Returns

1 Month Return: -10.71 %
3 Month Return: -14.79 %
1 Year Return: + 153.78 %
3 Year Return: -40.09 %
5 Year Return: -90.27 %

NextCure Inc Stock Fundamentals & Key Indicators

Check NextCure Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.2M

EPS (TTM)

-8.2067

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-55.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-111.23%

NextCure Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NextCure Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
NextCure Inc	BUY	$39.2M	-90.27%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$42.7B	130.51%	136.81	8.45%
Vertex Pharmaceuticals Inc	BUY	$110.8B	98.57%	28.42	32.94%
BeiGene, Ltd.	NA	$36.8B	NA	129.84	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	48.43%	17.98	31.41%

Stock Returns calculator for NextCure Inc Stock including INR - Dollar returns

The NextCure Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

NextCure Inc investment value today

Current value as on today

₹2,55,920

Returns

₹1,55,920

(+155.92%)

Returns from NextCure Inc Stock

₹1,35,566 (+135.57%)

Dollar Impact

₹20,354 (+20.35%)

Analyst Recommendation on NextCure Inc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for NextCure Inc. Average target price of $17.67

NextCure Inc Share Price Target

Get share price movements and forecasts by analysts on NextCure Inc.

What analysts predicted

42.28%UPSIDE

Target Price

$17.67

Current Price

$10.2

Analyzed by

10 Analysts

Target

$17.67

NextCure Inc target price $17.67, a slight upside of 42.28% compared to current price of $10.2. According to 10 analysts rating.

NextCure Inc Stock’s Investor Sentiment and Interest

Search interest for NextCure Inc Stock has increased by 120% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 19, 2026 to April 18, 2026

Change:120% versus previous 30 day period

NextCure Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	6	-	-	-	3	-	-	-	-
Gross Profit	0	5	0	0	0	1	0	0	-	0
Operating Income	-15	-15	-18	-16	-12	-12	-11	-27	-8	-9
EBITDA	-14	-14	-14	-15	-11	-11	-10	-26	-8	-9
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-14	-17	-15	-11	-11	-10	-26	-8	-9
Income Tax Expense	0	0	0	-	-	-	-	-	-	-
Net Income	-14	-14	-17	-15	-11	-11	-10	-26	-8	-9
Net Profit Margin	0.00%	-230.22%	0.00%	0.00%	0.00%	-353.53%	0.00%	0.00%	0.00%	0.00%

NextCure Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	6	22	-	-	-	-	-
Gross Profit	0	-1	-27	22	-4	-4	-3	-2	-2
Operating Income	-15	-23	-37	-41	-70	-75	-67	-59	-57
EBITDA	-14	-21	-34	-37	-66	-71	-63	-54	-55
Interest Expense	-	-	0	0	0	5	-	-	-
Depreciation	0	1	2	3	7	4	3	2	2
Income Before Tax	-15	-22	-33	-36	-69	-74	-62	-55	-55
Income Tax Expense	-	0	2	-3	6	-5	-	-	-
Net Income	-15	-22	-33	-33	-69	-69	-62	-55	-55
Net Profit Margin	0.00%	0.00%	-531.54%	-148.32%	0.00%	0.00%	0.00%	0.00%	0.00%

NextCure Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-14	-17	-15	-11	-11	-10	-26	-8	-9
Operating Cash Flow	-10	-12	-9	-11	-6	-12	-22	-6	-7
Investing Cash Flow	4	17	12	18	6	7	3	8	6
Financing Cash Flow	0	0	0	0	0	-	2	-	20
Change in Cash	-6	5	2	6	0	-5	-16	2	18

NextCure Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-22	-33	-36	-69	-74	-62	-55	-55
Operating Cash Flow	7	-35	-44	-57	-53	-52	-40	-49
Investing Cash Flow	-3	-303	43	36	67	39	55	25
Financing Cash Flow	121	243	-1	-3	0	0	0	22
Change in Cash	126	-96	-2	-23	14	-13	14	-1

Global Institutional Holdings in NextCure Inc

Funds	Holdings
SILVERARC CAPITAL MANAGEMENT, LLC	4.94%
Bank of America Corp	0%
Awm Investment Company Inc	3.3%
UBS Group AG	0.02%
CARDIFF PARK ADVISORS, LLC	0.82%

See all

Insights on NextCure Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NXTC has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 61.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, NXTC stock has moved down by -5.5%

About NextCure Inc

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.

Organisation	NextCure Inc
Headquarters	9000 Virginia Manor Road, Beltsville, MD, United States, 20705
Industry	Biotechnology
CEO	Mr. Michael S. Richman MSBA
E-voting on shares	Click here to vote

Key Management of NextCure Inc

Name	Title
Dr. Sebastien Maloveste Ph.D.	Senior Vice President of Business Development
Dr. Udayan Guha M.D., Ph.D.	Chief Medical Officer
Mr. Michael S. Richman MSBA	Co-Founder, CEO, President & Director
Dr. Timothy Mayer Ph.D.	Chief Operating Officer
Dr. Lieping Chen M.D., Ph.D.	Co-Founder & Chairman of Scientific Advisory Board
Mr. Steven P. Cobourn CPA	Chief Financial Officer
Mr. Kevin G. Shaw	Senior VP & General Counsel
Mr. Sourav Kundu Ph.D.	Senior Vice President of Development & Manufacturing

FAQs

What is NextCure Inc share price today?

NextCure Inc share price today is $10.2 as on April 18, 2026 at 1:29 am IST at the close of the market. NextCure Inc share today touched a day high of $11.05 and a low of $10.13.

What is the 52 week high and 52 week low for NextCure Inc share?

NextCure Inc share touched a 52 week high of $15.74 on November 24, 2025 and a 52 week low of $3.85 on April 17, 2025. NextCure Inc stock price today i.e. April 18, 2026 at 1:29 am IST is closed at $10.2,which is 35.20% down from its 52 week high and 164.80% up from its 52 week low.

What is NextCure Inc's market capitalisation today?

NextCure Inc market capitalisation is $0.00T as on April 18, 2026 at 1:29 am IST.

How to invest in NextCure Inc Stock (NXTC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for NextCure Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NextCure Inc Shares that will get you 0.1471 shares as per NextCure Inc share price of $10.2 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy NextCure Inc Stock (NXTC) from India?

Indian investors can start investing in NextCure Inc (NXTC) shares with as little as ₹92.768 or $1 (as of April 18, 2026 at 5:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in NextCure Inc stock (as per the Rupee-Dollar exchange rate as on April 18, 2026 at 5:40 am IST). Based on NextCure Inc share’s latest price of $10.2 as on April 18, 2026 at 1:29 am IST, you will get 0.9804 shares of NextCure Inc. Learn more about fractional shares .

What are the returns that NextCure Inc has given to Indian investors in the last 5 years?

NextCure Inc stock has given -90.27% share price returns and 24.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?